secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2026-01-08T23:59:59+00:00
Accession:  0001829126-26-000110
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KALA BIO enters $15M at-market offering agreement with H.C. Wainwright
----------------------------------------------------------------------

- Aggregate market value of shares eligible for sale under ATM prospectus supplement currently $15,000,000.
- Sales commission to H.C. Wainwright set at 3.0% of gross sales price.
- Company has no obligation to sell any shares under the agreement; either party may suspend offerings.
- Subject to terms, Wainwright may sell shares on Nasdaq or in privately negotiated transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626000110/0001829126-26-000110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626000110/kalabio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-000110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer